Thalidomide fails to help patients with malignant pleural mesothelioma

A Dutch-Australian collaborative study has found thalidomide does not slow
progression nor improve survival in patients with malignant pleural mesothelioma (MPM), a scientific conference of cancer experts in Perth will be told today